Advertisement

Tandem Therapies in Extracorporeal Support

  • Rachel Sirignano
  • Meral Patel
  • Matthew L. PadenEmail author
Chapter

Abstract

Continuous renal replacement therapy (CRRT) has traditionally been used in patients with single organ failure who are hemodynamically unstable enough to tolerate intermittent hemodialysis. However, as technology advances and patient populations become more complex, there are an increasing number of patients with multi-organ failure who require multiple methods of extracorporeal organ support. While theoretical contraindications exist with each established extracorporeal device, additional circuits may be connected in tandem to each other to provide simultaneous extracorporeal organ support. In this chapter, we will discuss the use of multiple extracorporeal therapies, such as extracorporeal membrane oxygenation (ECMO) for cardiac and pulmonary failures, the use of apheresis procedures for liver failure support, in conjunction with CRRT for renal support to provide a total platform of extracorporeal life support (ECLS).

Keywords

Extracorporeal membrane oxygenation Tandem Apheresis Plasma exchange Extracorporeal life support 

References

  1. 1.
    Selewski DT, Charlton JR, Jetton JG, Guillet R, Mhanna MJ, Askenazi DJ, et al. Neonatal acute kidney injury. Pediatrics. 2015;136(2):e463–73.CrossRefPubMedGoogle Scholar
  2. 2.
    Fortenberry JD, Paden ML, Goldstein SL. Acute kidney injury in children: an update on diagnosis and treatment. Pediatr Clin N Am. 2013;60(3):669–88.CrossRefGoogle Scholar
  3. 3.
    Honore PM, Jacobs R, Hendrickx I, Bagshaw SM, Joannes-Boyau O, Boer W, et al. Prevention and treatment of sepsis-induced acute kidney injury: an update. Ann Intensive Care. 2015;5(1):51.CrossRefPubMedPubMedCentralGoogle Scholar
  4. 4.
    Bellomo R, Kellum JA, Ronco C. Defining and classifying acute renal failure: from advocacy to consensus and validation of the RIFLE criteria. Intensive Care Med. 2007;33(3):409–13.CrossRefPubMedGoogle Scholar
  5. 5.
    Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative workgroup. Acute renal failure—definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care. 2004;8(4):R204–12.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, et al. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care. 2007;11(2):R31.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Askenazi DJ, Ambalavanan N, Hamilton K, Cutter G, Laney D, Kaslow R, et al. Acute kidney injury and renal replacement therapy independently predict mortality in neonatal and pediatric noncardiac patients on extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2011;12(1):e1–6.CrossRefPubMedGoogle Scholar
  8. 8.
    Smith AH, Hardison DC, Worden CR, Fleming GM, Taylor MB. Acute renal failure during extracorporeal support in the pediatric cardiac patient. ASAIO J. 2009;55(4):412–6.CrossRefPubMedGoogle Scholar
  9. 9.
    Lou S, MacLaren G, Paul E, Best D, Delzoppo C, Butt W. Hemofiltration is not associated with increased mortality in children receiving extracorporeal membrane oxygenation. Pediatr Crit Care Med. 2015;16(2):161–6.CrossRefPubMedGoogle Scholar
  10. 10.
    Gadepalli SK, Hirschl RB. Extracorporeal life support: updates and controversies. Semin Pediatr Surg. 2015;24(1):8–11.CrossRefPubMedGoogle Scholar
  11. 11.
    Luo XJ, Wang W, Hu SS, Sun HS, Gao HW, Long C, et al. Extracorporeal membrane oxygenation for treatment of cardiac failure in adult patients. Interact Cardiovasc Thorac Surg. 2009;9(2):296–300.CrossRefPubMedGoogle Scholar
  12. 12.
    Selewski DT, Askenazi DJ, Bridges BC, Cooper DS, Fleming GM, Paden ML, et al. The impact of fluid overload on outcomes in children treated with extracorporeal membrane oxygenation: a multicenter retrospective cohort study. Pediatr Crit Care Med. 2017;18(12):1126–35.CrossRefPubMedGoogle Scholar
  13. 13.
    Arikan AA, Zappitelli M, Goldstein SL, Naipaul A, Jefferson LS, Loftis LL. Fluid overload is associated with impaired oxygenation and morbidity in critically ill children. Pediatr Crit Care Med. 2012;13(3):253–8.CrossRefPubMedGoogle Scholar
  14. 14.
    Sutherland SM, Zappitelli M, Alexander SR, Chua AN, Brophy PD, Bunchman TE, et al. Fluid overload and mortality in children receiving continuous renal replacement therapy: the prospective pediatric continuous renal replacement therapy registry. Am J Kidney Dis. 2010;55(2):316–25.CrossRefGoogle Scholar
  15. 15.
    Davison D, Basu RK, Goldstein SL, Chawla LS. Fluid management in adults and children: core curriculum 2014. Am J Kidney Dis. 2014;63(4):700–12.CrossRefPubMedGoogle Scholar
  16. 16.
    Roy BJ, Cornish JD, Clark RH. Venovenous extracorporeal membrane oxygenation affects renal function. Pediatrics. 1995;95(4):573–8.PubMedGoogle Scholar
  17. 17.
    Swaniker F, Kolla S, Moler F, Custer J, Grams R, Barlett R, et al. Extracorporeal life support outcome for 128 pediatric patients with respiratory failure. J Pediatr Surg. 2000;35(2):197–202.CrossRefPubMedGoogle Scholar
  18. 18.
    Weber TR, Kountzman B. Extracorporeal membrane oxygenation for nonneonatal pulmonary and multiple-organ failure. J Pediatr Surg. 1998;33(11):1605–9.CrossRefPubMedGoogle Scholar
  19. 19.
    Kelly RE Jr, Phillips JD, Foglia RP, Bjerke HS, Barcliff LT, Petrus L, et al. Pulmonary edema and fluid mobilization as determinants of the duration of ECMO support. J Pediatr Surg. 1991;26(9):1016–22.CrossRefPubMedGoogle Scholar
  20. 20.
    Selewski DT, Cornell TT, Blatt NB, Han YY, Mottes T, Kommareddi M, et al. Fluid overload and fluid removal in pediatric patients on extracorporeal membrane oxygenation requiring continuous renal replacement therapy. Crit Care Med. 2012;40(9):2694–9.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Goldstein S, Bagshaw S, Cecconi M, Okusa M, Wang H, Kellum J, et al. Pharmacological management of fluid overload. Br J Anaesth. 2014;113(5):756–63.CrossRefPubMedGoogle Scholar
  22. 22.
    Rosner MH, Ostermann M, Murugan R, Prowle JR, Ronco C, Kellum JA, et al. Indications and management of mechanical fluid removal in critical illness. Br J Anaesth. 2014;113(5):764–71.CrossRefPubMedGoogle Scholar
  23. 23.
    Fleming GM, Askenazi DJ, Bridges BC, Cooper DS, Paden ML, Selewski DT, et al. A multicenter international survey of renal supportive therapy during ECMO: the kidney intervention during extracorporeal membrane oxygenation (KIDMO) group. ASAIO J. 2012;58(4):407–14.CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Chen H, Yu RG, Yin NN, Zhou JX. Combination of extracorporeal membrane oxygenation and continuous renal replacement therapy in critically ill patients: a systematic review. Crit Care. 2014;18(6):675.CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Askenazi DJ, Selewski DT, Paden ML, Cooper DS, Bridges BC, Zappitelli M, et al. Renal replacement therapy in critically ill patients receiving extracorporeal membrane oxygenation. Clin J Am Soc Nephrol. 2012;7(8):1328–36.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Laverdure F, Masson L, Tachon G, Guihaire J, Stephan F. Connection of a renal replacement therapy or plasmapheresis device to the ECMO circuit. ASAIO J. 2017;64(1):122–5.CrossRefGoogle Scholar
  27. 27.
    Jenkins R, Harrison H, Chen B, Arnold D, Funk J. Accuracy of intravenous infusion pumps in continuous renal replacement therapies. ASAIO J. 1992;38(4):808–10.PubMedGoogle Scholar
  28. 28.
    Sucosky P, Dasi LP, Paden ML, Fortenberry JD, Yoganathan AP. Assessment of current continuous hemofiltration systems and development of a novel accurate fluid management system for use in extracorporeal membrane oxygenation. J Med Dev, Transactions of the ASME. 2008;2(3):035002.Google Scholar
  29. 29.
    Symons JM, McMahon MW, Karamlou T, Parrish AR, McMullan DM. Continuous renal replacement therapy with an automated monitor is superior to a free-flow system during extracorporeal life support. Pediatr Crit Care Med. 2013;14(9):e404–8.CrossRefPubMedGoogle Scholar
  30. 30.
    Santiago MJ, Sanchez A, Lopez-Herce J, Perez R, del Castillo J, Urbano J, et al. The use of continuous renal replacement therapy in series with extracorporeal membrane oxygenation. Kidney Int. 2009;76(12):1289–92.CrossRefPubMedGoogle Scholar
  31. 31.
    Shum HP, Kwan AM, Chan KC, Yan WW. The use of regional citrate anticoagulation continuous venovenous hemofiltration in extracorporeal membrane oxygenation. ASAIO J. 2014;60(4):413–8.CrossRefPubMedGoogle Scholar
  32. 32.
    Barbaro RP, Paden ML, Guner YS, Raman L, Ryerson LM, Alexander P, et al. Pediatric extracorporeal life support organization registry international report 2016. ASAIO J. 2017;63(4):456–63.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Thiagarajan RR, Barbaro RP, Rycus PT, McMullan DM, Conrad SA, Fortenberry JD, et al. Extracorporeal life support organization registry international report 2016. ASAIO J. 2017;63(1):60–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Selewski DT, Askenazi DJ, Bridges BC, Cooper DS, Fleming GM, Paden ML, Verway M, Sahay R, King E, Zappitelli M. The impact of fluid overload on outcome of children treated with extracorporeal membrane oxygenation: a multicenter retrospective cohort study. Pediatr Crit Care Med. 2017;18(12):1126–35.CrossRefPubMedGoogle Scholar
  35. 35.
    Kawai Y, Cornell TT, Cooley EG, Beckman CN, Baldridge PK, Mottes TA, et al. Therapeutic plasma exchange may improve hemodynamics and organ failure among children with sepsis-induced multiple organ dysfunction syndrome receiving extracorporeal life support. Pediatr Crit Care Med. 2015;16(4):366–74.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Schwartz J, Padmanabhan A, Aqui N, Balogun RA, Connelly-Smith L, Delaney M, et al. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the American society for apheresis: the seventh special issue. J Clin Apher. 2016;31(3):149–62.PubMedGoogle Scholar
  37. 37.
    Sirignano RM, Meyer EK, Fasano R, Paden ML. Pediatric tandem therapeutic apheresis: a multidisciplinary approach. ASAIO J. 2017.  https://doi.org/10.1097/MAT.0000000000000641.
  38. 38.
    Nguyen TC, Cruz MA, Carcillo JA. Thrombocytopenia-associated multiple organ failure and acute kidney injury. Crit Care Clin. 2015;31(4):661–74.CrossRefPubMedPubMedCentralGoogle Scholar
  39. 39.
    Dyer M, Neal MD, Rollins-Raval MA, Raval JS. Simultaneous extracorporeal membrane oxygenation and therapeutic plasma exchange procedures are tolerable in both pediatric and adult patients. Transfusion. 2014;54(4):1158–65.CrossRefPubMedGoogle Scholar
  40. 40.
    Bridges BC, Hardison D, Pietsch J. A case series of the successful use of ECMO, continuous renal replacement therapy, and plasma exchange for thrombocytopenia-associated multiple organ failure. J Pediatr Surg. 2013;48(5):1114–7.CrossRefPubMedGoogle Scholar
  41. 41.
    Jamal JA, Economou CJ, Lipman J, Roberts JA. Improving antibiotic dosing in special situations in the ICU: burns, renal replacement therapy and extracorporeal membrane oxygenation. Curr Opin Crit Care. 2012;18(5):460–71.CrossRefPubMedGoogle Scholar
  42. 42.
    Hohenforst-Schmidt W, Petermann A, Visouli A, Zarogoulidis P, Darwiche K, Kougioumtzi I, et al. Successful application of extracorporeal membrane oxygenation due to pulmonary hemorrhage secondary to granulomatosis with polyangiitis. Drug Des Devel Ther. 2013;7:627–33.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Patel P, Nandwani V, Vanchiere J, Conrad SA, Scott LK. Use of therapeutic plasma exchange as a rescue therapy in 2009 pH1N1 influenza A--an associated respiratory failure and hemodynamic shock. Pediatr Crit Care Med. 2011;12(2):e87–9.CrossRefPubMedGoogle Scholar
  44. 44.
    Tabbutt S, Leonard M, Godinez RI, Sebert M, Cullen J, Spray TL, et al. Severe influenza B myocarditis and myositis. Pediatr Crit Care Med. 2004;5(4):403–6.CrossRefPubMedGoogle Scholar
  45. 45.
    Mok Q, Butt W. The outcome of children admitted to intensive care with meningococcal septicaemia. Intensive Care Med. 1996;22(3):259–63.CrossRefPubMedGoogle Scholar
  46. 46.
    Maclaren G, Butt W, Cameron P, Preovolos A, McEgan R, Marasco S. Treatment of polypharmacy overdose with multimodality extracorporeal life support. Anaesth Intensive Care. 2005;33(1):120–3.PubMedGoogle Scholar
  47. 47.
    Nasir S, Kilic YA, Karaaltin MV, Erdem Y. Lessons learned from the first quadruple extremity transplantation in the world. Ann Plast Surg. 2014;73(3):336–40.PubMedGoogle Scholar
  48. 48.
    Barnes SL, Naughton M, Douglass J, Murphy D. Extracorporeal membrane oxygenation with plasma exchange in a patient with alveolar haemorrhage secondary to Wegener’s granulomatosis. Intern Med J. 2012;42(3):341–2.CrossRefPubMedGoogle Scholar
  49. 49.
    Ahmed SH, Aziz T, Cochran J, Highland K. Use of extracorporeal membrane oxygenation in a patient with diffuse alveolar hemorrhage. Chest. 2004;126(1):305–9.CrossRefPubMedGoogle Scholar
  50. 50.
    Yusuff H, Malagon I, Robson K, Parmar J, Hamilton P, Falter F. Extracorporeal membrane oxygenation for life-threatening ANCA-positive pulmonary capillaritis. A review of UK experience. Heart Lung Vessel. 2015;7(2):159–67.PubMedPubMedCentralGoogle Scholar
  51. 51.
    Joseph M, Charles AG. Early extracorporeal life support as rescue for Wegener granulomatosis with diffuse alveolar hemorrhage and acute respiratory distress syndrome: a case report and literature review. Pediatr Emerg Care. 2011;27(12):1163–6.CrossRefPubMedGoogle Scholar
  52. 52.
    Di Maria MV, Hollister R, Kaufman J. Case report: severe microscopic polyangiitis successfully treated with extracorporeal membrane oxygenation and immunosuppression in a pediatric patient. Curr Opin Pediatr. 2008;20(6):740–2.CrossRefPubMedGoogle Scholar
  53. 53.
    Dalabih A, Pietsch J, Jabs K, Hardison D, Bridges BC. Extracorporeal membrane oxygenation as a platform for recovery: a case report of a child with pulmonary hemorrhage, refractory hypoxemic respiratory failure, and new onset goodpasture syndrome. J Extra Corpor Technol. 2012;44(2):75–7.PubMedPubMedCentralGoogle Scholar
  54. 54.
    Hites M, Dell’Anna AM, Scolletta S, Taccone FS. The challenges of multiple organ dysfunction syndrome and extra-corporeal circuits for drug delivery in critically ill patients. Adv Drug Deliv Rev. 2014;77:12–21.CrossRefPubMedGoogle Scholar
  55. 55.
    Nguyen TC, Han YY, Kiss JE, Hall MW, Hassett AC, Jaffe R, et al. Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. Crit Care Med. 2008;36(10):2878–87.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Kolovos NS, Schuerer DJ, Moler FW, Bratton SL, Swaniker F, Bartlett RH, et al. Extracorporal life support for pulmonary hemorrhage in children: a case series. Crit Care Med. 2002;30(3):577–80.CrossRefPubMedGoogle Scholar

Copyright information

© Springer International Publishing AG, part of Springer Nature 2018

Authors and Affiliations

  • Rachel Sirignano
    • 1
  • Meral Patel
    • 1
  • Matthew L. Paden
    • 1
    Email author
  1. 1.Division of Pediatric Critical CareEmory UniversityAtlantaUSA

Personalised recommendations